Talecris Biotherapeutics files for $1 bln IPO

WASHINGTON, July 27 Fri Jul 27, 2007 6:06pm EDT

WASHINGTON, July 27 (Reuters) - Biopharmaceutical firm Talecris Biotherapeutics Holdings Corp. said on Friday it is planning a $1 billion initial public offering of common stock.

Morgan Stanley, Goldman Sachs & Co. and JPMorgan, will underwrite the IPO, according to a preliminary offering document filed with the U.S. Securities and Exchange Commission.

The Research Triangle Park, North Carolina-based company is seeking a Nasdaq listing under the symbol "TLCR."

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.